Case Report

Pulmonary Hemorrhage Syndrome Associated with an Autochthonous Case of Dengue Hemorrhagic Fever

Authors: MAJ Robert F. Setlik, MD, PHD, MC, USA, COL Daniel Ouellette, MD, MC, USA, COL Julia Morgan, DO, MC, USA, COL C. Kenneth McAllister, MD, MC, USA, LTC David Dorsey, MD, MC, USA, MAJ Brian K. Agan, MD, MC, USAF, MAJ Lynn Horvath, MD, MC, USA, CPT Michelle K. Zimmerman, MD, MC, USAF, MAJ Bret Purcell, MD, PHD, MC, USA

Abstract

Dengue fever is a major public health problem worldwide. Dengue hemorrhagic fever, a much rarer form of the disease, occurs when a person previously infected with dengue is re-infected with a different viral serotype. In recent years the infection rates of dengue and both clinical syndromes have increased along the United States-Mexico border. We present the case of a 61-year-old Laotian female who presented with a 1-week history of fever, altered mental status, oral ulceration, and rash. The patient developed diffuse pulmonary hemorrhage and anemia requiring multiple transfusions. She eventually sustained multi-organ system failure and expired. Both the titer data and serologies were consistent with the diagnosis of dengue hemorrhagic fever. We hypothesize that this syndrome was the result of re-infection occurring within the United States. This case is also unusual in that it is the second reported in the literature of pulmonary hemorrhages associated with dengue hemorrhagic fever.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Halstead SB. Dengue hemorrhagic fever-a public health problem and a field for research. Bull of the WHO 1980;58(1):1–21.
 
2. Gubler DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 1998;11:480–496.
 
3. Gubler DJ and Kuno G (eds):Dengue and Dengue Hemorrhagic Fever. London, CAB International, 1997, pp 1–22.
 
4. McSherry JA. Some medical aspects of the Darien Scheme: was it dengue?Scottish Med J1982;27:183–184.
 
5. Kuno G. Review of the factors modulating dengue transmission. Epidemiologic Rev 1995;17(2):321–335.
 
6. Dengue Hemorrhagic Fever: Diagnosis, Treatment, Prevention and Control. Geneva, Switzerland, World Health Organization, 1997, ed 2, pp 1–11.
 
7. Nelson ER. Haemorrhagic fever in children in Thailand. J Paediatrics 1960;56:101–108.
 
8. Liam CK, Yap BH, and Lam SK. Dengue fever complicated by pulmonary haemorrhage manifesting as haemoptysis. J Trop Med & Hygiene 1993;96:197–200.
 
9. Morens, M., Halstead SB, Repik PM, et al. Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells: comparison of the BHK suspension test with standard plaque reduction neutralization. J Clin Microbiol 1985;22(2):250–254.
 
10. Hayes GC, Manaloto CR, Gonzales A, et al. Dengue infections in the Philippines: clinical and virological findings in 517 hospitalized patients. Am J of Trop Med & Hygiene 1988;39:110–116.
 
11. Rodriguez-Tan RS, and Weir MR. Dengue: a review. Texas Med 1998;94(10):53–59.